Home > Boards > US Listed > Miscellaneous > Orgenesis Inc (ORGS)

Belenger Olivier has filed a new activist 13D,

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
wiltonio Member Profile
 
Followed By 13
Posts 562
Boards Moderated 0
Alias Born 04/05/16
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/21/2020 3:30:57 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/27/2020 8:37:11 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/25/2020 6:07:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2020 4:01:16 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 11/16/2020 5:03:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 2:37:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2020 6:17:28 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 11:01:53 AM
Orgenesis Third Quarter 2020 Revenue Increases 40% Reflecting Continued Progress of POCare Platform GlobeNewswire Inc. - 11/5/2020 8:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/3/2020 4:30:49 PM
Orgenesis Announces Virtual 2020 Annual Meeting of Stockholders GlobeNewswire Inc. - 11/3/2020 3:14:57 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/22/2020 4:27:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/21/2020 12:30:51 PM
Orgenesis Completes Acquisition of Koligo Therapeutics and Announces Additional Acquisition of Icellator® Technology from Ti... GlobeNewswire Inc. - 10/19/2020 6:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/1/2020 5:05:22 PM
Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies GlobeNewswire Inc. - 9/29/2020 6:30:10 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/25/2020 5:25:53 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/23/2020 5:03:01 PM
Orgenesis CEO to Participate in Webinar Panel on “New Approaches to COVID-19” on Thursday, September 10th GlobeNewswire Inc. - 9/9/2020 7:00:10 AM
Orgenesis Selects Therapeutics, Inc. as CRO to Support Development and Planned Phase 2 Clinical Study of Ranpirnase for the T... GlobeNewswire Inc. - 8/20/2020 7:30:10 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/14/2020 4:16:10 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/7/2020 11:33:52 AM
Orgenesis Second Quarter 2020 Revenue Increases 55% Reflecting Progress of POCare Platform GlobeNewswire Inc. - 8/7/2020 7:30:10 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2020 4:26:45 PM
Orgenesis to Collaborate with Educell to Conduct Clinical Validation of Cell Therapies Using Orgenesis’ Proprietary POCare ... GlobeNewswire Inc. - 7/14/2020 7:00:10 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences